The relative importance of dopamine and norepinephrine in mediating locomotor activity
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aghajanian, 1977, Dopamine “autoreceptor” pharmacological characterization by microintophoretic single cell recording studies, Naunyn-Schmiedeb. Arch. Pharmacol., 297, 1, 10.1007/BF00508803
Ahlenius, 1973, Restoration of locomotor activity in mice by low l-DOPA doses after supression by α-methyltyrosine but not by reserpine, Brain Res., 62, 567, 10.1016/0006-8993(73)90627-6
Aim, 1976, Piperidine: effects on LA and brain monoamine turnover, Psychopharmacology, 50, 301, 10.1007/BF00426848
Anden, 1977, Functional effects of local injections of dopamine and analogs into the neostriatum and nucleus accumbens, 385
Anden, 1973, Release of dopamine from central noradrenaline and dopamine newes induced by a dopamine-β-hydroxylase inhibitor, J. Neural Transm., 34, 93, 10.1007/BF01244662
Anden, 1970, Evidence for a central noradrenaline receptor stimulation by clonidine, Life Sci., 9, 513, 10.1016/0024-3205(70)90207-9
Anden, 1966, Functional role of the nigro-neostriatal Dopamine neuron, Acta Pharmacol. Toxicol., 24, 263, 10.1111/j.1600-0773.1966.tb00389.x
Anden, 1976, Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neuron in the brain, Eur. J. Pharmacol., 39, 275, 10.1016/0014-2999(76)90136-9
Anden, 1977, Inhibitory effect of gamma-hydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantic migra, Naunyn. Schmeid. Arch. Pharmacol., 279, 89, 10.1007/BF00502071
Anden, 1973, Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity, Psychopharmacol., 29, 289, 10.1007/BF00429276
Anisman, 1975, Central effects of scopolamine and (+)-amphetamine on LA: interaction with strain and stress variables, Neurophormacology, 14, 835, 10.1016/0028-3908(75)90111-2
Antelman, 1977, Norepinephrine-dopamine interactions and behavior, Science, 195, 646, 10.1126/science.841304
Arnfeld, 1968, Cholinergic mechanism in brain inhibiting amphetamine induced stereotyped behavior, Acta Pharmacol. Toxicol., 26, 384, 10.1111/j.1600-0773.1968.tb00457.x
Baez, 1976, Effects of drugs on arousal and consummatory behavior, 140
Baley, 1981, Chronic l-DOPA treatment of mice: behavior and biochemistry, J. Neural Transm., 50, 209, 10.1007/BF01249143
Baldessarini, 1975, Differential effects of serotonin on turning and stereotype induces by apomorphine, Brain Res., 93, 158, 10.1016/0006-8993(75)90295-4
Banerjee, 1973, On the mechanism of central action of amphetamine: The role of Catecholamines, Neuropharmacology, 12, 917, 10.1016/0028-3908(73)90023-3
Barnett, 1968, The biological properties of optical isomers of propranolol and their effects on cardiac arrhythmias, Brit. J. Pharmacol., 34, 43, 10.1111/j.1476-5381.1968.tb07949.x
Bartholini, 1968, Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase, J. Pharm. Pharmacol., 20, 228, 10.1111/j.2042-7158.1968.tb09726.x
Bell, 1970, Time course of the effects of 6-hydroxydopamine on catecholamine containing neurons in rat hypothalamus and striatum, Brit. J. Pharmacol., 40, 790, 10.1111/j.1476-5381.1970.tb10655.x
Benkert, 1973, Dopamine noradrenaline and 5-hydroxytryptamine in relative to motor activity fighting and mounting behavior, Neuropharmacology, 12, 177, 10.1016/0028-3908(73)90102-0
Blaschko, 1960, The decarboxylation of amrio acids related to tyrosine and their awakening action in reserpine treated mice, J. Physiol., 151, 272, 10.1113/jphysiol.1960.sp006437
Boissier, 1966, De la potentialisation des effets de la DOPA par les inhibiteurs de la monoanincoxydase, Psychopharmacology, 8, 428, 10.1007/BF00406491
Borbely, 1973, Physiological and behavioral effects of parachlorophenylalanine in the rat, Psychopharmacology, 31, 131, 10.1007/BF00419813
Breese, 1975, Comparison of tyrosine hydroxylase and dopamine-β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity, Psychopharmacologia, 36, 1
Breese, 1974, Evidence for the involvement of 5-hydroxytryptamine in the actions of amphetamine, Brit. J. Pharmacol., 52, 307, 10.1111/j.1476-5381.1974.tb09714.x
Breese, 1971, Depletion of brain NE and DA by 6-OHDA, Brit. J. Pharmacol., 42, 88, 10.1111/j.1476-5381.1971.tb07089.x
Brook, 1975, Changed eating and locomotor activity behavior in the rat after 6-hydroxydopamine lesions to the substantia nigra, Neuropharmacology, 14, 95, 10.1016/0028-3908(75)90032-5
Bryson, 1973, Effect of 6-hydroxydopamine pretreatment upon l-DOPA induced scatter jumping in mice, Res. Comm. Pathol. Pharmacol., 6, 613
Burt, 1977, Antischizophrenic drugs: chronic treatment elevates, 196, 326
Butcher, 1969, Behavioral and biochemical effects of l-DOPA after peripheral decarboxylase inhibition, Brain Res., 15, 233, 10.1016/0006-8993(69)90322-9
Butcher, 1972, Behavioral, biochemical and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition, Brain Res., 41, 387, 10.1016/0006-8993(72)90510-0
Cannon, 1976, Potentiation of amphetamine induced hyperactivity by acute but not chronic parachlorophenylalamine treatment in the rat, Life Sci., 18, 763, 10.1016/0024-3205(76)90189-2
Carlsson, 1967, Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate, J. Pharm. Pharmacol., 19, 481, 10.1111/j.2042-7158.1967.tb08116.x
Chalmers, 1971, Effects of l-DOPA on norepinephrine metabolism in the brain, 68, 662
Cheramy, 1978, GABA engic processes controlling DA release in cat, Eur. J. Pharmacol., 48, 281, 10.1016/0014-2999(78)90087-0
Chrusciel, 1969, Effects of dopalanine on behavior in mice depleted of norepinephrine or serotonin, Psychopharmacologia, 14, 124, 10.1007/BF00403685
Constaninidis, 1968, Accumulation of DA in the parenchyma after decarboxylase inhibition in the capallanes of brain, Experientia, 24, 130, 10.1007/BF02146939
Cools, 1981, The puzzling “cascade” of multiple receptor for dopamine, Trends Pharmacol. Sci., 2, 178, 10.1016/0165-6147(81)90305-9
Cools, 1982, Antipsychotic and motor effects of neuroleptic agents: neurochemical and neurobiological aspects, 73
Cools, 1978, Functional antagonism between DA and NE within caudate nucleus of cats: rhythmically changing susceptibility, Psychopharmacology, 59, 221, 10.1007/BF00426627
Corrodi, 1970, Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-β-hydroxylase, Brain. Res., 24, 451, 10.1016/0006-8993(70)90185-X
Costa, 1972, Effects of amphetamine on the turnover rate of brain catecholamines and motor activity, Brit. J. Pharmacol., 44, 742, 10.1111/j.1476-5381.1972.tb07312.x
Costall, 1980, Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the NAS: Interaction at presynaptic receptors?, Europ. J. Pharmacol., 63, 347, 10.1016/0014-2999(80)90265-4
Costall, 1979, Cholinorgic and dopaminergic mechanisms in the nucleus accumbens controlling locomotor activity, Brit. J. Pharmacol., 66, 121
Costall, 1981, Characterisation of the mechanisms by which purported DA agonists reduce locomotor activity in mice, Eur. J. Pharmacol., 73, 175, 10.1016/0014-2999(81)90089-3
Costall, 1972, Stereotyped behavior patterns and hyperactivity induced by amphetamine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei, Br. Res., 123, 89, 10.1016/0006-8993(77)90645-X
Costall, 1973, The role of the substantia nigra in the locomotor stimulation by amphetamine, Brit. J. Pharmacol., 49, 29, 10.1111/j.1476-5381.1973.tb08265.x
Costall, 1975, Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi, J. Pharm. Pharmacol., 27, 875, 10.1111/j.2042-7158.1975.tb10237.x
Costall, 1975, The behavioral effects of dopamine applied intracerebrally to areas of the system, Eur. J. Pharmacol., 32, 87, 10.1016/0014-2999(75)90326-X
Costall, 1975, Neuroleptic antagonism of dyskinetic phenomena, Europ. J. Pharmacol., 33, 301, 10.1016/0014-2999(75)90174-0
Costall, 1976, Serotonergic modulation of the dopamine response from the nucleus accumbens, J. Pharm. Pharmacol., 28, 523, 10.1111/j.2042-7158.1976.tb02783.x
Costall, 1976, Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiriole and thioridazine, Eur. J. Pharmacol., 35, 161, 10.1016/0014-2999(76)90311-3
Costall, 1976, A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride, and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems, Eur. J. Pharmacol., 40, 9, 10.1016/0014-2999(76)90348-4
Costall, 1977, Differentiation of the dopamine mechanisms mediating stereotyped behavior and hyperactivity in the nucleus accumbens and caudate-putamen, J. Pharm. Pharmacol., 29, 337, 10.1111/j.2042-7158.1977.tb11331.x
Costall, 1977, Mesolimbic and extraphyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat, Vol. 21, 47
Costall, 1978, Neuroleptic interaction with the serotonergic-dopaminergic mechanisms in the nucleus accumbens, J. Pharm. Pharmacol., 30, 257, 10.1111/j.2042-7158.1978.tb13220.x
Costall, 1980, Assessment of the test-procedures used to analyse neuroleptic action, Rev. Pure Applied Pharmacol. Sci., 1, 1
Costall, 1975, Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi, J. Pharm. Pharmacol., 27, 875, 10.1111/j.2042-7158.1975.tb10237.x
Costall, 1979, Hyperactivity response to apomorphine and amphetamine in mouse: the importance of nucleus accumbens and caudate-putamen, Commun. J. Pharm. Pharmacol., 31, 259, 10.1111/j.2042-7158.1979.tb13494.x
Costall, 1972, Stereotypic and anticataleptic activities of amphetamic after intracerebral injections, Eur. J. Pharmacol., 18, 83, 10.1016/0014-2999(72)90135-5
Costall, 1974, Design of agents for stimulation of neostriatal dopaminergic mechanisms, J. Pharm. Pharmacol., 26, 753, 10.1111/j.2042-7158.1974.tb09170.x
Costall, 1976, Characterization of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethanolamine deviatives, Psychopharmacology, 48, 225, 10.1007/BF00423265
Creese, 1982, Dopamine receptors explained, Trends Neurol. Sci., 3, 40, 10.1016/0166-2236(82)90019-4
Creese, 1972, Amphetamine response in rat after dopamine neuron destruction, Nature, 238, 247
Creese, 1973, Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine, Brain Res., 55, 369, 10.1016/0006-8993(73)90302-8
Creese, 1975, Pharmacological and anatomical substrates of amphetamine response in rat, Brain Res., 83, 419, 10.1016/0006-8993(75)90834-3
Creese, 1981, Receptor adaptations to centrally acting drugs, Ann. Rev. Pharmacol. Toxicol., 21, 357, 10.1146/annurev.pa.21.040181.002041
Creveling, 1968, The combined use of α-methyltyrosine and threo-dihydroxyphenylserine-selective reduction of dopamine in the central neurons system, Biochem. Pharmacol., 17, 65, 10.1016/0006-2952(68)90158-5
Dandiya, 1974, A comparison of d- and l-amphetamine on open field activity of rats, Psychopharmacology, 39, 67, 10.1007/BF00421459
Davidson, 1972, l-Dopa induced stimulation of locomotor activity, Vol. 6, 387
de Champlain, 1971, Degeneration and regrowth of adrenergic new fibers in the rat peripheral tissues after 6-hydroxydopamine, Canad. J. Physiol. Pharmacol., 49, 345, 10.1139/y71-038
Delini-Stula, 1976, Inhibitory effects of properanolol and oxprenolol on excitation induced by a MAO inhibitor and reserpine in mouse, Neuropharmacology, 15, 383, 10.1016/0028-3908(76)90113-1
Del Rio, 1969, Further studies on the antagonism of stereotyped behavior induced by amphetamine, Eur. J. Pharmacol., 8, 73, 10.1016/0014-2999(69)90130-7
Descarries, 1972, Disappearance of the locus coeruleus in the rat after intraventricular 6-hydroxydopamine, Brain Res., 37, 310, 10.1016/0006-8993(72)90676-2
DiChiara, 1978, Self-inhibitory DA receptors: Their role in effects of low doses of apomorphine, Vol. 19, 275
DiChiara, 1977, Postsynaptic receptors are not essential for dopaminergic feedback regulation, Nature, 267, 270, 10.1038/267270a0
DiChiara, 1977, Haloperidol increases and apomorphine decreases striatal DA metabolism after destruction of DA sensitive adenylate cylase by kainic acid, Brain Res., 130, 374, 10.1016/0006-8993(77)90286-4
Dolphin, 1976, Relative importance of DA and NE receptor stimulation for restoration of reserpine or α-methyl-p-tyrosine pretreated mice, Pharmacol. Biochem. Behav., 4, 661, 10.1016/0091-3057(76)90217-3
Donaldson, 1976, NE and DA in controversive circling seen after unilateral electrolytic lesions of the locus coeruleus, Eur. J. Pharmacol., 39, 179, 10.1016/0014-2999(76)90126-6
Dunstan, 1977, The effect of apomorphine and clonidine on LA in mice after long-term treatment with haloperidol, Clin. Exp. Pharmacol. Physiol., 4, 131, 10.1111/j.1440-1681.1977.tb02613.x
Dunstan, 1979, Long-term haloperidol-treatment of mice: a change in β-adrenergic receptor responsiveness, J. Neural Transmission, 44, 187, 10.1007/BF01253062
Elephteriow, 1972, Circadian rhythm in blood and brain biogenic ammes and other biochemical changes in rabbit, Brain Res., 75, 145
Elkhawad, 1975, Studies on the behavioral pharmacology of a cyclic analogue of dopamine following its injection into the brains of conscious rats, Brit. J. Pharmacol., 54, 107, 10.1111/j.1476-5381.1975.tb07416.x
Ellison, 1978, Structural and biochemical alterations in DA innervation of the caudate nucleus following continuous amphetamine administration, Science, 201, 276, 10.1126/science.26975
Erinoff, 1979, Age-dependent effects of 6-OHDA on locomotor activity in the rat, Brain Res., 164, 195, 10.1016/0006-8993(79)90015-5
Ernst, 1969, The role of biogenic amines in the extrapyramidal system, Acta Physiol. Pharmacol., 15, 141
Estler, 1979, Influence of pimozide on LA hyperactivity produced by caffeine, J. Pharm. Pharmacol. Commun., 31, 126, 10.1111/j.2042-7158.1979.tb13453.x
Estler, 1971, Modification by two β-adrenergic blocking drugs of the effects of methamphetamine on behavior and brain metabolism of mice, J. Neurochem., 18, 777, 10.1111/j.1471-4159.1971.tb12007.x
Everett, 1970, l-Dopa: Effect on concentrations of dopamine, norepinephrine and serotonin in brains of mice, Science, 168, 849, 10.1126/science.168.3933.849
Evetts, 1970, Effects of 6-hydroxydopamine on CNS Catecholamines, spontaneous motor activity and amphetamine induced hyperactivity in rats, Nature (London), 225, 961, 10.1038/225961a0
Faull, 1969, Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra, Exper. Neurol., 23, 332, 10.1016/0014-4886(69)90081-8
Feeney, 1979, Sensory neglect after lesions of substantia nigra or lateral hypothalamus-differential severity and recovery, Brain Res., 178, 329, 10.1016/0006-8993(79)90697-8
Feigenbaum, 1982, The effect of naloxone on d-amphetamine induced locomotor activity, Res. Commun. Subst. Abuse, 3, 379
Feigenbaum, 1982, The role of dopamine and norepinephrine uptake inhibition in mediating the action of d-amphetamine induced locomotor activity, Res. Commun. Chem. Pathol. Pharmacol., 35, 333
Fibiger, 1971, The effect of para-chlorophenylalanine on spontaneous locomotor activity in the rat, Neuropharmacol., 10, 25, 10.1016/0028-3908(71)90005-0
Fibiger, 1973, Attenuation of amphetamine induced locomotor stimulation and stereotypy by 6-hydroxydopamine in the rat, Brit. J. Pharmacol., 47, 683, 10.1111/j.1476-5381.1973.tb08194.x
Fibiger, 1973, Regulatory deficits after unilateral electrolytic or 6-OHDA lesions of the substantia nigra, Am. J. Physiol., 225, 282, 10.1152/ajplegacy.1973.225.6.1282
Fink, 1981, Genetic variations in midbrain dopamine cell number: different responses to dopaminergic agonists and dopamine mediated behaviors, Brain Res., 222, 335, 10.1016/0006-8993(81)91037-4
Fog, 1971, Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats, Exper. Neurol., 31, 75, 10.1016/0014-4886(71)90178-6
Fog, 1970, Lesions in corpus striatum and cortex of rat brain and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behavior, Psychopharmacology, 18, 346, 10.1007/BF00402761
Forssberg, 1973, The locomotion of acute spinal cat injected with clonidine iv, Brain Res., 50, 184, 10.1016/0006-8993(73)90606-9
Fuxe, 1971, dl-5-hydroxytryptophan induced changes in central monoamine neurons after peripheral decarboxylase inhibition, J. Pharm. Pharmacol., 23, 420, 10.1111/j.2042-7158.1971.tb08673.x
Fuxe, 1970, Morphological and functional aspects of central monoamine neurons, Vol. 13, 93
Fuxe, 1970, Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration, 257
Gaddy, 1977, Differential behavioral changes following intrastriatal application of 6-hydroxydopamine, Brain Res., 119, 439, 10.1016/0006-8993(77)90322-5
Gerson, 1980, Motor effects of serotonin in the central nervous system, Life Sci., 27, 1435, 10.1016/0024-3205(80)90368-9
Gessa, 1968, Selective increase of brain dopamine induced by α-hydroxybutyrate: study of the mechanism of action, J. Neurochem., 15, 377, 10.1111/j.1471-4159.1968.tb11624.x
Gessa, 1968, Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines, Life Sci., 7, 289, 10.1016/0024-3205(68)90202-6
Glick, 1977, Behavioral effects of amphetamine in brain damaged animals: Problems in the search for sites of action, 77
Glick, 1974, Shifting of the d-amphetamine dose-response curve in rats with frontal cortical ablations, Psychopharmacologia, 36, 109, 10.1007/BF00421782
Goldstein, 1966, Inhibition of norepinephrine biosynthesis at the dopamine-β-hydroxylase stage, Pharmacol. Rev., 18, 77
Grabowska, 1974, Influence of midbrain raphe lesion on some pharmacological and biochemical effects of apomorphine in rats, Psychopharmacology, 39, 315, 10.1007/BF00422971
Grabowska, 1973, Apomorphine and central serotonin neurons, Pol. J. Pharmacol., 25, 29
Grabowska, 1974, On the role of serotonin in apomorphine induced stimulation in rats, Pharmacol. Biochem. Behav., 2, 263, 10.1016/0091-3057(74)90063-X
Grahame-Smith, 1972, Prevention by inhibitors of brain protein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of l-tryptophan or 5-methoxy-N, N-dimethyltryptamine, J. Neurochem., 19, 2409, 10.1111/j.1471-4159.1972.tb01295.x
Graybiel, 1979, Fiber connections of basalganglia, Vol. 51, 239
Green, 1974, Enhancement of amphetamine action after interruption of ascending serotonergic pathways, J. Pharmacol. Exp. Therap., 190, 109
Groves, 1981, Changes in dopamine terminal excitability by amphetamine and haloperidol, Brain Res., 221, 425, 10.1016/0006-8993(81)90795-2
Haggendal, 1971, The recovery of noradrenaline in adrenergic nerve terminals of the rat after reserpine treatment, J. Pharm. Pharmacol., 23, 81, 10.1111/j.2042-7158.1971.tb08617.x
Handley, 1978, Influence of catecholamines on dexamphetamine-induced changes in LA, Psychopharmacology, 58, 283, 10.1007/BF00427392
Harik, 1973, The effects of lesions in the head of the caudate nucleus on spontaneous and l-DOPA induced activity in the cat, Brain Res., 62, 279, 10.1016/0006-8993(73)90642-2
Hasselager, 1972, Specific antagonism by dopamine inhibitors of items of amphetamine induced agressive behavior, Psychopharmacology, 24, 485, 10.1007/BF00423439
Heal, 1978, Studies on LA by injection of dibutyryl cyclic 3′5′AMP into the nucleus accumbens of rats, Neuropharmacology, 17, 265, 10.1016/0028-3908(78)90110-7
Hefti, 1981, The site of DA formation in rat striatum after l-dopa administration, J. Pharmacol. Exper. Ther., 217, 189
Herman, 1973, Influence of noradrenaline, 5-hydroxytryptamine and acetylcholine injected intraventricularly on the rat's behavior, Acta Physiol. Pol., 24, 87
Herman, 1975, Behavioral changes induced in conscious mice by intracerebroventricular injection of catecholamines, acetylcholine and 5-hydroxytryptamine, Br. J. Pharmacol., 55, 351, 10.1111/j.1476-5381.1975.tb06938.x
Hirschhorn, 1982, Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat, Brain Res., 234, 357, 10.1016/0006-8993(82)90875-7
Hitzemann, 1971, Effect of para-methoxyamphetamine on catacholamine metabolism in the mouse brain, Life Sci., 10, 1087, 10.1016/0024-3205(71)90227-X
Hiorth, 1980, A new centrally acting DA-receptor agonist with selectivity for autoreceptors, 290, 177
Hokfelt, 1973, Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurons, Brain Res., 60, 269, 10.1016/0006-8993(73)90791-9
Hollister, 1974, Comparison of tyrosine hydroxylase and dopamine-β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatment on d-amphetamine induced motor activity, Psychopharmacology, 36, 1, 10.1007/BF00441377
Hollister, 1976, An inhibitory role for brain seratonin containing systems in the locomotor effects of d-amphetamine, J. Pharmacol. Exper. Therap., 198, 12
Horn, 1971, Catecholmine uptake by synaptosome from rat brain: structure activity relationships of drugs with differential effects on dopamine and norepinephrine neurons, Molec. Pharmacol., 7, 66
Hornykiewicz, 1972, Dopamine and its physiological significance in brain function, 6, 367
Hornykiewicz, 1974, The mechanism of l-dopa in Parkinson's disease, Life Sci., 15, 1249, 10.1016/0024-3205(74)90306-3
Horton, 1977, Circling behavior in rodents following imbalance of basal ganglia GABA concentrations, Pharmacol. Biochem. Behav., 6, 493, 10.1016/0091-3057(77)90107-1
Hruska, 1979, Quantitative aspects of normal locomotion in rats, Life Sciences, 25, 171, 10.1016/0024-3205(79)90389-8
Huang, 1981, d-Amphetamine at low doses suppresses noradrenergic functions, Eur. J. Pharmacol., 75, 187, 10.1016/0014-2999(81)90544-6
Iversen, 1971, Role of transmitter uptake mechanisms in synaptic neurotransmission, Brit. J. Pharmacol., 41, 571, 10.1111/j.1476-5381.1971.tb07066.x
Iversen, 1981, 305
Iversen, 1979, Pharmacodynamics of antidepressants and antimanic drugs, 60
Jackson, 1975, A functional effect of dopamine in the nucleus accumbens and in some other dopamine rich parts of the rat brain, Psychopharmacol., 45, 139, 10.1007/BF00429052
Jacobs, 1974, Effect of two dopamine receptor blockers on serotonin mediated behavioral syndrome in rats, Eur. J. Pharmacol., 27, 363, 10.1016/0014-2999(74)90014-4
Jacobs, 1976, An animal behavior model for studying central serotonergic synapses, Life Sci., 19, 777, 10.1016/0024-3205(76)90303-9
Jacobs, 1974, A comparison of the locomotor effects of 5-hydroxytryptamine and 5-hydroxytryptophan administered via two systemic routes, Pharmacol. Biochem. Behav., 2, 137, 10.1016/0091-3057(74)90148-8
Javoy, 1976, Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system, Brain Res., 102, 201, 10.1016/0006-8993(76)90877-5
John, 1958, Differential effect of reserpine on conditioned responses, Science, 127, 25, 10.1126/science.127.3288.25-a
Johnson, 1970, In vivo inhibition of dopamine β-hydroxylase by u-14,624, J. Pharmacol. Exper. Therap., 171, 80
Joseph, 1978, Age related changes in nigrostriatum: behavior and biochemistry, J. Gerontol., 33, 643, 10.1093/geronj/33.5.643
Joyce, 1981, Behavioral effects of unilateral DA injection into dorsal or ventral striatum, Eur. J. Pharmacol., 72, 1, 10.1016/0014-2999(81)90290-9
Joyce, 1964, Eating, drinking and activity in rats following 5-HTP administration, Psychopharmacol., 5, 417, 10.1007/BF02193478
Katz, 1978, Enhancement of drug-induced LA by an inhibitor of phenylethanolamine-N-methyltransferase, Neurosci. Lett., 8, 83, 10.1016/0304-3940(78)90102-7
Kelly, 1976, Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant induced locomotor activity in rats, Eur. J. Pharmacol., 40, 45, 10.1016/0014-2999(76)90352-6
Kelly, 1976, Actions of aporphine alkaloids on locomotor activity in rats with 6-OHDA lesions of the nucleus accumbens, Eur. J. Pharmacol., 35, 85, 10.1016/0014-2999(76)90303-4
Kelly, 1975, Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens and corpus striatum, Brain Res., 94, 507, 10.1016/0006-8993(75)90233-4
Kemp, 1982, Circadian variations of noradrenaline, 5-hydroxytryptamine and dopamine in specific brain areas of C57 B1/6 and BALB-c mice, Brain Res., 232, 472, 10.1016/0006-8993(82)90291-8
Kleinrik, 1970, Some central effects of diethyldithiocarbamate administered intraventricularly in rats, Neuropharmacol., 9, 451, 10.1016/0028-3908(70)90018-3
Kostrzewa, 1973, Acute effects of 6-hydroxydopa on central monoaminergic neurons, Eur. J. Pharmacol., 21, 70, 10.1016/0014-2999(73)90209-4
Ksiazek, 1974, Central action of β-adrenergic receptor blocking agents. I. Central action of intraventricularly administered isoprenaline in rat, Pol. J. Pharmacol., 26, 287
Lal, 1975, Effect of amphetamine and apomorphine on brain monoamines and behavior in immature and young adult rat, Arch. Internat'l. Pharmacol. Therap., 218, 239
Lassen, 1976, Inhibition and potentiation of apomorphine induced hypermotility in rats by neuroleptics, Eur. J. Pharmacol., 36, 385, 10.1016/0014-2999(76)90092-3
Lassen, 1977, Inhibition of apomorphine induced hypermotility in rats by chlorpromazine, perphenazine, thioridazive and melperone, Acta Pharmacol. Toxicol., 40, 418, 10.1111/j.1600-0773.1977.tb02093.x
Leonard, 1979, Pharmacological and biochemical aspects of hyperkinetic disorders, Neuropharmacol., 18, 923, 10.1016/0028-3908(79)90156-4
Leszkovsky, 1900, Some effects of propranolol on the nervous system, J. Pharm. Pharmacol., 17, 518, 10.1111/j.2042-7158.1965.tb07715.x
Ljungberg, 1977, Different behavioral patterns induced by apomorphine: evidence that the method of administration determines the behavioral response to the drug, Eur. J. Pharmacol., 46, 41, 10.1016/0014-2999(77)90142-X
Ljungberg, 1978, Classification of neuroleptics by their ability to inhibit apomorphine-induced LA and growing: evidence for two mechanisms of action, Psychopharmacology, 56, 239, 10.1007/BF00432845
Lloyd, 1900, Neurotransmitter interactions related to central DA neurons, Vol. 5, 129
Lloyd, 1975, Catecholamines in regulation of motor function, Vol. 1, 41
Lorens, 1970, Lesions of the nucleus accumbens septi of the rat: Behavioral and neurochemical effects, J. Comp. Physiol. Psychol., 73, 284, 10.1037/h0030204
Lorens, 1971, Behavioral and neurochemical effects of lesions in the raphe system of the rat, J. Comp. Physiol. Psychol., 77, 48, 10.1037/h0031572
Lyon, 1977, The action of central nervous system stimulant drugs, Vol. 2, 89
Mabry, 1973, Serotonergic inhibition of catecholamine induced behavioral arousal, Brain Res., 49, 381, 10.1016/0006-8993(73)90429-0
Maj, 1972, Effect of apomorphine on motility in rats, Eur. J. Pharmacol., 17, 208, 10.1016/0014-2999(72)90160-4
Maj, 1971, The effect of l-DOPA on brain catecholamines and motility in rats, Psychopharmacology, 22, 162, 10.1007/BF00403624
Maj, 1975, Serotonergic mechanism of clonidine and apomorphine interaction, Pol. J. Pharmacol. Pharm., 27, 27
Maj, 1973, Effects of amantadine, amphetamine and apomorphine on the locomotor activity in rats, Life Sci., 12, 511, 10.1016/0024-3205(73)90203-8
Maj, 1972, The effect of clonidine on locomotor activity in mice, Life Sci., 11, 483, 10.1016/0024-3205(72)90198-1
Maj, 1972, The effect of l-dopa and (+)-amphetamine on LA after pinozide and phenoxybenzamine, J. Pharm. Pharmacol., 24, 412, 10.1111/j.2042-7158.1972.tb09020.x
Malec, 1972, The spontaneous motility of rats after intraventricular injection of dopamine, Neuropharmacologia, 11, 331, 10.1016/0028-3908(72)90018-4
Marsden, 1976, Studies on the behavioral effects of tryptophan and p-chlorophenylalanine, Neuropharmacol., 15, 165, 10.1016/0028-3908(76)90025-3
Marsden, 1978, The contribution of tryptamine to the behavioral effects of l-tryptophan in tranylcypromine treated rats, Psychopharmacology, 57, 71, 10.1007/BF00426960
Marsden, 1979, The role of tryptamine in the behavioral effects of tranylcypromine + l-tryptophan, Neuropharmacology, 18, 159, 10.1016/0028-3908(79)90056-X
Marshall, 1979, Somatosensory inattention after dopamine-depleting intra-cerebral 6-OHDA injections Spontaneous recovery and pharmacological control, Brain Res., 177, 311, 10.1016/0006-8993(79)90782-0
Mayer, 1971, The effect of diethyldithiocarbamate on amphetamine-induced behavior in rats, J. Pharm. Pharmacol., 23, 894, 10.1111/j.2042-7158.1971.tb10215.x
McDevitt, 1981, Differential effects of DA agonists in mature and immature rats, Eur. J. Pharmacol., 72, 69, 10.1016/0014-2999(81)90298-3
Melamed, 1980, l-3,4-dihydroxyphenylalanine and l-5-hydroxytryptophan decarboxylase activities in rat striatum: effect of selective DA or serotinergic input, J. Neurochem., 34, 1753, 10.1111/j.1471-4159.1980.tb11270.x
Menon, 1973, Studies on the mechanism of the akinetic effects of gamma hydroxybutyric acid and 1,4-butanediol, Arch. Int. Pharmacodyn., 203, 232
Messing, 1976, Effects of chloroamphetamine on locomotor activity and brain 5-hydroxynidoles, Neuropharmacol., 15, 157, 10.1016/0028-3908(76)90024-1
Miller, 1981, Magnitude and duration of hyperactivity following neonatal 6-OHDA is related to the extent of brain dopamine depletion, Brain Res., 229, 123, 10.1016/0006-8993(81)90750-2
Modigh, 1973, Effects of l-tryptophan on motor activity in mice, Psychopharmacology, 30, 123, 10.1007/BF00421427
Modigh, 1974, Functional aspects of 5-hydroxytryptamine turnover in the central nervous system, Acta Physiol. Scand. Suppl., 403, 1
Mogenson, 1980, From motivation to action: functional interface between the limbic system and the motor system, Prog. Neurobiol., 14, 69, 10.1016/0301-0082(80)90018-0
Moore, 1969, Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice, Biochem. Pharmacol., 18, 1627, 10.1016/0006-2952(69)90150-6
Moore, 1979, Central catecholamine and neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems, Ann. Rev. Neurosci., 2, 113, 10.1146/annurev.ne.02.030179.000553
Moore, 1976, Release of neurotransmitters from the brain in vivo by amphetamine, meshylphenidate and cocaine, 143
Moore, 1967, Reversal of α-methyltyrosine induced behavioral depression with dihydroxyphenylalanine and amphetamine, J. Pharm. Pharmacol., 19, 405, 10.1111/j.2042-7158.1967.tb09571.x
Moore, 1979, Regulation of nigrostriatal and tuberoinfundibular-hypophyseal dopaminergic neurons, Prog. Neurobiol., 13, 325, 10.1016/0301-0082(79)90019-4
Morgan, 1980, Effect of catecholaminergic and serotonergic neurotoxins on the locomotor responses in the cat, Anat. Rec., 196, 129A
Nahorski, 1975, Behavioral supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine, Psychopharmacology, 42, 159, 10.1007/BF00429547
Naylor, 1972, Modification of the behavioral changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus, Neuropharmacology, 11, 91, 10.1016/0028-3908(72)90060-3
Neill, 1974, Impairment of avoidance performance by intrastriatal administration of 6-hydroxydopamine, J. Comp. Physiol. Psychol., 86, 1019, 10.1037/h0037633
Neuberg, 1974, Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-DOPA: Possible involvement of seratonin, Biol. Psychiatr., 8, 139
Nicksolson, 1981, Detailed analysis of the effects of apomorphine and d-amphetamine on spontaneous locomotor behavior of rats measured in a TV-based, automated open-field system, Eur. J. Pharmacol., 72, 45, 10.1016/0014-2999(81)90295-8
Nielsen, 1980, Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine, Eur. J. Pharmacol., 66, 149, 10.1016/0014-2999(80)90137-5
Nieouillon, 1979, Effects of unilateral nigral application of DA drugs on in vivo release of DA in two caudate nuclei of cat, Eur. J. Pharmacol., 53, 289, 10.1016/0014-2999(79)90135-3
North, 1974, Amphetamine isomers: Influences on locomotor and stereotyped behavior of cats, Pharmacol. Biochem. Behav., 2, 115, 10.1016/0091-3057(74)90143-9
Nowycky, 1978, Dopaminergic neurons: role of presynaptic receptors in the regulation of transmitter biosynthesis, Prog. Neuropsychopharmacol., 2, 139, 10.1016/0364-7722(78)90061-9
Oka, 1976, Effect of p-chlorophenylalanine on the rethidine or methadone induced decrease in locomotor activity in rats, Eur. J. Pharmacol., 37, 393, 10.1016/0014-2999(76)90049-2
Parksepp, 1973, Noradrenergic pathways and sleep-waking states in cats, Exper. Neurol., 41, 233, 10.1016/0014-4886(73)90265-3
Pettinger, 1977, Recent advances in the treatment of hypertension, Arch. Intern. Med., 137, 679, 10.1001/archinte.137.5.679
Punenburg, 1976, Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity, Eur. J. Pharmacol., 35, 45, 10.1016/0014-2999(76)90299-5
Punenburg, 1975, Inhibition of d-amphetamine induced locomotor activity by injection of Haloperidol into the nucleus accumbens septi of the rat, Psychopharmacologia, 41, 87, 10.1007/BF00421062
Punenburg, 1973, Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens, J. Pharm. Pharmacol., 25, 1003, 10.1111/j.2042-7158.1973.tb09995.x
Poirier, 1972, Non-specific histopathological changes induced by intracerebral injection of 6-hydroxy-dopamine, J. Neural Sci., 16, 401, 10.1016/0022-510X(72)90047-0
Ponzio, 1981, Differential effects on drugs on striatal dopamine metabolites, Neuro Sci. Lett., 27, 61, 10.1016/0304-3940(81)90206-8
Price, 1974, Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra, Eur. J. Pharmacol., 29, 249, 10.1016/0014-2999(74)90023-5
Puech, 1974, Apomorphine neuropsychopharmacological spectrum of activity, J. Pharmacol. (Paris), 5, 241
Pycock, 1982, Behavioral and biochemical changes following chronic administration of l-DOPA to rats, Eur. J. Pharmacol., 79, 201, 10.1016/0014-2999(82)90626-4
Pycock, 1975, Circling behavior by unilateral lesions in locus coeruleus in rats, Brain Res., 97, 317, 10.1016/0006-8993(75)90453-9
Pycock, 1978, The rotating rodent: a two component systems?, Eur. J. Pharmacol., 47, 167, 10.1016/0014-2999(78)90388-6
Pycock, 1978, Manipulation of cholinergic mechanisms on turning behavior in mice with unilateral destruction of nigronestriatal DA system, Neuropharmacology, 17, 175, 10.1016/0028-3908(78)90097-7
Randrup, 1972, Mechanisms by which amphetamine produces stereotypy, agression, and other behavioral effects, Psychopharmacology, 26
Randrup, 1966, Diethyldithiocarbamate and amphetamine stereotyped behavior, J. Pharm. Pharmacol., 18, 752, 10.1111/j.2042-7158.1966.tb07799.x
Ranje, 1977, High correlation between number of dopamine cells, dopamine levels and motor performance, Brain Res., 134, 83, 10.1016/0006-8993(77)90927-1
Reichenberg, 1973, Intraventicular injections of l-DOPA: The effect on rat locomotor activity and body temperature, Eur. J. Pharmacol., 22, 376, 10.1016/0014-2999(73)90043-5
Robbins, 1982, Functional systems of the central catecholamines, Int. Rev. Neurobiol., 23, 303, 10.1016/S0074-7742(08)60628-5
Roberts, 1978, 6-OHDA lesions to dorsal noradrenergic bundle alters morphine-induced locomotor and catalepsy, Eur. J. Pharmacol., 52, 209, 10.1016/0014-2999(78)90208-X
Roberts, 1975, Ascending catecholamine induced locomotor activity: importance of dopamine and norepinephrine, Brain Res., 93, 441, 10.1016/0006-8993(75)90182-1
Rolinski, 1973, Tissue concentrations of digoxin in an autopsy material, Acta Pharmacol. Toxicol., 33, 385, 10.1111/j.1600-0773.1973.tb01540.x
Rosencrans, 1967, Effects of an acute stressor on the brain amine levels of normal and CNS lesioned rats, Pharmacologist, 9, 224
Roth, 1970, Mechanism of the α-hydroxybutyrate induced increase in brain dopamine and its relationship to sleep, Biochem. Pharmacol., 19, 3001, 10.1016/0006-2952(70)90086-9
Sachs, 1972, Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxydopa, J. Neurochem., 19, 1561, 10.1111/j.1471-4159.1972.tb05100.x
Sanberg, 1981, Kainic acid injections in the striatum alter cataleptic and locomotor effects of drugs influencing dopaminergic and cholinergic systems, Eur. J. Pharmacol., 74, 347, 10.1016/0014-2999(81)90054-6
Saunders-Bush, 1970, p-Chloroamphetamine: In vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin, J. Pharmacol. Exper. Therap., 175, 419
Scatton, 1977, Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration, Eur. J. Pharmacol., 46, 363, 10.1016/0014-2999(77)90230-8
Scheckel, 1969, Hyperactive states related to the metabolism of norepinephrine and similar biochemicals, Ann. N.Y. Acad. Sa., 159, 939, 10.1111/j.1749-6632.1969.tb12990.x
Scheel-Kruger, 1977, Musicol a GABA-agonist in the NAS increases apomorphine stereotypy and decreases motility, Life Sci., 21, 1697, 10.1016/0024-3205(77)90250-8
Scheel-Kruger, 1967, Stereotype hyperactive behavior produced by dopamine in the absence of noradrenaline, Life Sci., 6, 1389, 10.1016/0024-3205(67)90186-5
Scheving, 1968, Daily fluctuation (circadian and ultradian) in biogenic amines of rat brain, Am. J. Physiol., 214, 166, 10.1152/ajplegacy.1968.214.1.166
Schlechter, 1972, Blockade by pimozide of (-)-amphetamine induced hyperkinseia in mice, J. Pharm. Pharmacol., 24, 408, 10.1111/j.2042-7158.1972.tb09018.x
Scotti de Carolis, 1971, Central effects of 6-hydroxydopamine, Physiol. Behav., 7, 705, 10.1016/0031-9384(71)90135-1
Segal, 1976, Differential effects of para-chlorophenylalanine on amphetamine induced locomotion and stereotypy, Brain Res., 116, 267, 10.1016/0006-8993(76)90904-5
Seiden, 1964, Brain and heart catecholamine levels after l-DOPA administration in reserpine treated mice: Correlations with a conditioned avoidance response, Psychopharmacology, 5, 178, 10.1007/BF00413240
Serra, 1979, Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on DA synthesis and motor activity, Life Sci., 25, 415, 10.1016/0024-3205(79)90573-3
Shanks, 1976, The properties of β-adrenoceptor antagonists, Postgrad. Med. J., 52, 14
Shaywitz, 1976, Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction, Science, 191, 305, 10.1126/science.942800
Shore, 1972, Transport and storage of biogenic amines, Ann. Rev. Pharmacol., 12, 209, 10.1146/annurev.pa.12.040172.001233
Simpson, 1976, Amphetamine and related stimulants in drug treatment of mental disorders, 161
Skirboll, 1979, DA auto- and postsynaptic receptors: Electro physiological evidence for differential sensitivity to DA agonists, Science, 206, 80, 10.1126/science.482929
Smith, 1965, Effects of d-amphetamine upon brain amine content and locomotor activity of mice, J. Pharmacol., Exper. Therap., 147, 96
Snyder, 1970, The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs, Am. J. Psychiatr., 127, 199, 10.1176/ajp.127.2.199
Sorenson, 1976, Amphetamine potentiation of locomotor activity after knife cut lesions of ascending catecholamine containing neurons, Neurosci. Abstr., 2, 505
Spehlman, 1976, Dopamine acetylcholine imbalance in Parkinson's disease, Lancet Apr., 3, 724, 10.1016/S0140-6736(76)93095-6
Spyraki, 1981, Behavioral evidence for supersensitivity of postsynaptic DA receptors in mesolimbic system after chronic desipramine, Eur. J. Pharmacol., 74, 195, 10.1016/0014-2999(81)90531-8
Steeves, 1980, Effect of noradrenaline and 5-hydroxytryptamine depletion on locomotion in cat, Brain Res., 185, 349, 10.1016/0006-8993(80)91073-2
Stone, 1974, Effect of intraventricular amines on motor activity in hypothermic rats, Res. Comm. Chem. Pathol. Pharmacol., 7, 549
Stoof, 1980, Simultaneous demonstration of activation of presynaptic DA autoreceptors and postsynaptic DA receptors by N,n-diproptyl-5,6-ADTN, Brain Res., 196, 276, 10.1016/0006-8993(80)90738-6
Strombom, 1976, Catecholamine receptor agonists effects on motor activity and tyrosine hydroxylation in mouse brain, Naunyn-Schmied. Arch. Pharmacol., 292, 167
Strombom, 1979, Qualitative aspects in motility changes in mice induced by low doses of apomorphine and elonidine, J. Neural. Transm., 45, 129, 10.1007/BF01250088
Svensson, 1970, The effect of inhibition of catecholamine synthesis on dexanphetamine induced central stimulation, Eur. J. Pharmacol., 12, 161, 10.1016/0014-2999(70)90061-0
Svensson, 1973, Dopamine release and direct dopamine receptor activation in the central nervous system by D- 145, an amantadine derivative, Eur. J. Pharmacol., 23, 232, 10.1016/0014-2999(73)90088-5
Svensson, 1969, On the significance of central noradrenaline for motor activity: Experiments with new dopamine-β-hydroxylase inhibitor, Eur. J. Pharmacol., 7, 278, 10.1016/0014-2999(69)90092-2
Svensson, 1970, On the role of brain catecholamines in motor activity: Experiments with inhibitors of synthesis and of monoamine oxidase, Psychopharmacology, 18, 357, 10.1007/BF00402762
Tassin, 1979, Collateral sprouting and reduced activity of rat mesocortical dopaminergic neurons after selective lesion of noadrenergic bundles, Neurosci., 4, 1569, 10.1016/0306-4522(79)90020-4
Taylor, 1974, Comparison between behaviors elicited by high doses of amphetamine and fenfluramine: Implications for the concept of stereotypy, Psychopharmacology, 40, 249, 10.1007/BF00429419
Taylor, 1971, The effect of drugs on the behavioral and biochemical actions of intraventricular 6-hydroxydopamine, Eur. J. Pharmacol., 17, 16, 10.1016/0014-2999(72)90263-4
Thoa, 1977, Isolation effects catecholamine concentration and turnover in discrete areas of rat brain, Brain Res., 131, 259, 10.1016/0006-8993(77)90519-4
Thornburg, 1971, Stress-related effects of various inhibitors of catecholamine synthesis in the mouse, Arch. Int. Pharmacodyn., 194, 158
Thornburg, 1973, The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs, Neuropharmacology, 12, 853, 10.1016/0028-3908(73)90038-5
Thut, 1970, Lack of tolerance to the central stimulant effects of d-amphetamine (dA) in rats, Pharmacologist, 12, 226
Tseng, 1974, Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro, J. Pharmacol. Exper. Therap., 189, 708
Tsutsumi, 1982, The short- and long-term effects of haloperidol on rat central dopamine turnover, Brain Res., 232, 485, 10.1016/0006-8993(82)90293-1
Ungerstedt, 1971, Post-synaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system, Acta Physio. Scand. Suppl., 367, 69, 10.1111/j.1365-201X.1971.tb11000.x
Ungerstedt, 1974, Behavioral physiological and neurochemical changes after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine neurons, Neurol., 5, 421
Ungerstedt, 1978, The role of dopamine as a neurotransmitter in the central and the autonomic nervous system, Acta Endocrinol., 216, 13
Ungerstedt, 1969, Direct chemical stimulation of DA in neostriatum of rat, Brain Res., 14, 461, 10.1016/0006-8993(69)90122-X
Van Ree, 1981, Injection of low doses of apomorphine into nucleus accumbens of rats reduces locomotor activity, Eur. J. Pharmacol., 72, 107, 10.1016/0014-2999(81)90305-8
van Rossum, 1962, Mechanism of action of cocaine and amphetamine in the brain, Experientia, 18, 229, 10.1007/BF02148316
Vetulani, 1973, Effect of dopamine-β-hydroxylase inhibitors on the rat brain monoamine content following intraventricular injection of 2-DOPA, Biochem. Pharmacol., 22, 1263, 10.1016/0006-2952(73)90300-6
Vetulani, 1974, Ineffectiveness of desipramine pretreatment on behavioral effects of 6-OHDA in nialamide-pretreated rats, Psychopharmacologia, 38, 173, 10.1007/BF00426111
Volicer, 1969, Conclation between behavioral and biochemical effects of p-chlorophenylalanine in mice and rats, J. Neuropharmacol., 8, 361, 10.1016/0028-3908(69)90022-7
von Arginer, 1967, Diethyldithiocarbamate activity on brain catecholamine spontaneous activity and l-DOPA hyperactivity, Med. Pharmacol., 17, 576
Walters, 1973, Dopaminergic neurons: Similar biochemical and histochemical effects of α-hydroxybutyrate and acute lesions of the nigroncostriatal pathway, J. Pharmacol. Exper, Therap., 186, 630
Weinstock, 1972, Influence of propranolol on some behavioral effects of amphetamine in cat, Brain Res., 42, 541, 10.1016/0006-8993(72)90563-X
Weinstock, 1973, The effect of dl-propranolol, d-propranolol and practolol on the hyperactivity induced in rats by prolonged isolation, Psychopharmacology, 30, 241, 10.1007/BF00422870
Weinstock, 1974, Modification by propranolol and related compounds of motor activity and stereotype behavior induced in the rat by amphetamine, Eur. J. Pharmacol., 25, 29, 10.1016/0014-2999(74)90090-9
Weissman, 1966, Antiamphetamine effects following inhibition of tyrosine hydroxylase, J. Pharmacol. Exper. Therap., 151, 339
Westermann, 1976, Effects of harmine and brain lesions on apomorphine induced motor activity, Pharmacol. Biochem. Behav., 4, 1, 10.1016/0091-3057(76)90166-0
Williams, 1981, Induction of swimming in the high spinal stingray by l-DOPA, Brain Res., 220, 208, 10.1016/0006-8993(81)90228-6
Wirtshafter, 1978, Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity, Eur. J. Pharmacol., 51, 449, 10.1016/0014-2999(78)90437-5
Woodruff, 1974, Long lasting stimulation of locomotor activity produced by intraventricular injection of a cyclic analogue of dopamine into conscious mice, Eur. J. Pharmacol., 25, 80, 10.1016/0014-2999(74)90097-1